The two volumes on Parkinson's disease in the Handbook of Clinical Neurology (Series Editors: Michael J. Aminoff, Department of Neurology, University of California, San Francisco, USA; Fran?§ois Boller, Bethesda, USA; Dick F. Swaab, Netherlands Institute for Neuroscience, Amsterdam, the Netherlands) cover a group of disorders that constitute the commonest of neurodegenerative diseases and one that is assuming ever greater importance with the ageing of the population in developed countries. The coverage reflects the dramatic advances in understanding of the biochemical background of parkinsonism and the resulting developments in the pharmacological management of the disease. These volumes give a comprehensive account of the subject for both clinical neurologists and those researching in the neurosciences.Part I covers the scientific background, general aspects of Parkinson's disease, clinical aspects and etiology. Part II covers the medical and surgical treatment of Parkinson's disease, complications of therapy and the other parkinsonian syndromes.
Author(s): William C. Koller MD PhD, Eldad Melamed MD
Edition: 1
Year: 2007
Language: English
Pages: 608
Cover......Page 1
Obituary......Page 2
Foreword......Page 3
Preface......Page 4
Contributors to Volume 84......Page 5
Contents......Page 11
30 Physical therapy in Parkinson's disease.pdf......Page 14
31 Neuroprotection in Parkinson's disease- clinical trials.pdf......Page 29
32 Levodopa.pdf......Page 42
33 Dopamine agonists.pdf......Page 84
34 Monoamine oxidase A and B inhibitors in Parkinson's disease.pdf......Page 104
35 Anticholinergic medications.pdf......Page 132
36 Antiglutamatergic drugs in the treatment of Parkinson's disease.pdf......Page 137
37 Investigational drugs.pdf......Page 147
38 The importance of patient groups and collaboration.pdf......Page 161
39 Motor and non-motor fluctuations.pdf......Page 166
40 Levodopa-induced dyskinesias in Parkinson's disease.pdf......Page 193
41 Treatment-induced mental changes in Parkinson's disease.pdf......Page 227
42 Ablative surgery for the treatment of Parkinson's disease.pdf......Page 249
43 Deep brain stimulation.pdf......Page 268
44 Transplantation.pdf......Page 285
45 Gene therapy approaches for the treatment of Parkinson's disease.pdf......Page 297
46 Multiple system atrophy.pdf......Page 311
47 Progressive supranuclear palsy.pdf......Page 332
48 Corticobasal degeneration.pdf......Page 355
49 Infectious basis to the pathogenesis of Parkinson's disease.pdf......Page 377
50 Toxic causes of parkinsonism.pdf......Page 389
51 Drug-induced parkinsonism.pdf......Page 403
52 Vascular parkinsonism.pdf......Page 421
53 Old age and Parkinson's disease.pdf......Page 430
54 Other degenerative processes.pdf......Page 448
55 Hydrocephalus and structural lesions.pdf......Page 461
56 Calcification of the basal ganglia.pdf......Page 481
57 Trauma and Parkinson's disease.pdf......Page 489
58 Psychogenic parkinsonism.pdf......Page 502
59 Parkinsonism and dystonia.pdf......Page 508
60 Dementia with Lewy bodies.pdf......Page 531
61 Myoclonus and parkinsonism.pdf......Page 549
Subject Index......Page 561
